Publication: Caged Activators of Artificial Allosteric Protein Biosensors – ACS Synthetic Biology
April 27th, 2020 A new approach to construction of two component biosensors was published by the group of Prof Alexandrov
April 27th, 2020 A new approach to construction of two component biosensors was published by the group of Prof Alexandrov
August 1st, 2020 Kirill Alexandrov (QUT), Professor Jacobus Ungerer (Pathology Queensland) and Molecular Warehouse received a AUD$635,000 Development grant from NHMRC to develop a Point-of-Care test for acute pancreatitis.
July 6th, 2020 A publication on biosensor research from Prof Alexandrov’s group is featured by Human Frontier Science Program: Towards cyborg biology – electrochemical biosensors of everything Background: The idea of combining man-made and natural systems has fascinated humans for…
July 6th, 2020A publication on biosensor research from Prof Alexandrov’s group is featured by Human Frontier Science Program
May 10th, 2019 A new study describing a general approach for construction of artificial protein biosensors is published by the group of Prof Alexandrov.
Molecular Warehouse, a top 10 finalist of the 2017 Pfizer Healthcare Hub (https://healthcarehub.pfizer.co.uk/2017-finalists), was one of only six startups internationally invited to present at the Pfizer EX global innovation conference from Pfizer, in New York, in March 2017. There were 300+…
Prof Kirill Alexandrov, in collaboration with Prof Evgeny Katz of Clarkson University (USA), the Institute of Nano- and Biotechnologies (Germany), and the Institute of Complex Systems (Germany), have published first results on the use of GDH-based biosensors for the continuous monitoring…
Innovate UK published an article on Molecular Warehouse, highlighting the success of the Development of Prototype grant it received in 2016. Click on title below to access article on Innovate UK website. Full text copied below. Molecular Warehouse: monitoring transplant…
Molecular Warehouse was selected from over 100 applications and 12 finalists as best Series A stage company at Health 2.0, the premier conference for digital health. The selection panel was composed of prestigious international life sciences and tech investors, including:…
Chiesi Pharmaceuticals Limited (“Chiesi”), an international research-focused Healthcare group, and Molecular Warehouse Ltd (“MW”), an innovative start up company developing mobile-enabled medical diagnostics, today announced the start of a collaboration to jointly develop a diagnostic system to enable transplant patients…